Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Regev Cohen is active.

Publication


Featured researches published by Regev Cohen.


Antimicrobial Resistance and Infection Control | 2017

A prospective survey of Pseudomonas aeruginosa colonization and infection in the intensive care unit

Regev Cohen; Frida Babushkin; Shoshana Cohen; Marina Afraimov; Maurice Shapiro; Martina Uda; Efrat Khabra; Amos Adler; Ronen Ben Ami; Svetlana Paikin

BackgroundPseudomonas aeruginosa (PA) surveillance may improve empiric antimicrobial therapy, since colonizing strains frequently cause infections. This colonization may be ‘endogenous’ or ‘exogenous’, and the source determines infection control measures. We prospectively investigated the sources of PA, the clinical impact of PA colonization upon admission and the dynamics of colonization at different body sites throughout the intensive care unit stay.MethodsIntensive care patients were screened on admission and weekly from the pharynx, endotracheal aspirate, rectum and urine. Molecular typing was performed using Enterobacterial Repetitive Intergenic Consensus Polymerase Chain reaction (ERIC-PCR).ResultsBetween November 2014 and January 2015, 34 patients were included. Thirteen (38%) were colonized on admission, and were at a higher risk for PA-related clinical infection (Hazard Ratio = 14.6, p = 0.0002). Strains were often patient-specific, site-specific and site-persistent. Sixteen out of 17 (94%) clinical isolates were identical to strains found concurrently or previously on screening cultures from the same patient, and none were unique. Ventilator associated pneumonia-related strains were identical to endotracheal aspirates and pharynx screening (87–75% of cases). No clinical case was found among patients with repeated negative screening.ConclusionPA origin in this non-outbreak setting was mainly ‘endogenous’ and PA-strains were generally patient- and site-specific, especially in the gastrointestinal tract. While prediction of ventilator associated pneumonia-related PA-strain by screening was fair, the negative predictive value of screening was very high.


BMJ Open | 2016

Treatment of febrile geriatric patients with suspected urinary tract infections in a hospital with high rates of ESBL producing bacteria: a cohort study

Zvi Shimoni; Regev Cohen; Ruslan Avdiaev; Paul Froom

Purpose To determine the consequences of treating febrile geriatric patients with a suspected urinary tract infection (UTI) with antibiotics that have high resistance rates due primarily to extended-spectrum β-lactamase (ESBL) producing bacteria. Methods In this cohort study, we selected 257 consecutive hospitalised patients aged ≥70 years with a chief symptom of fever, possibly due to a UTI and initially treated with antibiotics with rates in our hospital of urinary culture resistance >20%. Patients with severe sepsis were excluded. The main outcomes measures were in vitro bacterial resistance to initial antibiotic therapy (BRIAT), response to therapy, hospitalisation days and mortality. Results Urine cultures were positive in 64.2% (165 of 257) of the patients and BRIAT occurred in 28.0% (72 of 257). Response rates were 100% (93 of 93) in those with bacteria sensitive to initial antibiotic therapy, 95.7% (88 of 92) in the culture negative patients, and 66.7% (48 of 72) in those with BRIAT (p<0.001). There were no deaths due to deterioration during the initial treatment period because of BRIAT. In the patients with BRIAT, the median length of hospitalisation was 3 days longer than that in the other patients (7 and 4 days, respectively, p<0.001). Conclusions We conclude that initial broad spectrum antibiotic treatment could potentially lower the median length of hospitalisation by 3 days in many hospitalised geriatric patients without an extra-urinary tract source for their fever. This benefit needs to be balanced against the risk to the individual patient and to the general public of increasing bacterial resistance rates to broader spectrum antibiotics often held in reserve.


IDCases | 2018

Cryptococcosis as a cause of nephrotic syndrome? A case report and review of the literature

Regev Cohen; Frida Babushkin; Maurice Shapiro; Ronen Ben-Ami; Talya Finn

We present a case of a 74 years old male with cutaneous cryptococcosis of the right forearm. Cryptococcus neoformans var. neoformans was cultivated from the skin and from the bloodstream. He was diagnosed with nephrotic syndrome (focal segmental glomerulosclerosis) 21 months prior to admission, which was steroid-dependent. He was treated with prednisone and cyclosporine A. Concurrently with his renal disease he was also diagnosed as having disseminated severe tinea mannum, tinea corporis and tinea cruris; onychomycosis, skin eczema and psoriasis. After a prolonged course of anti-fungal therapy, his skin lesions as well as his nephrotic syndrome recovered completely. Follow up after 7 months without any anti-fungal or immunosuppression showed no skin or renal recurrence. We assume that the renal disease was related to the pre-existing cutaneous cryptococcosis, aggravated by immunosuppression, and discuss the close association between cutaneous cryptococcosis and nephrotic syndrome, as well as similar case reports in the literature.


Case Reports | 2018

Streptococcus anginosus endocarditis and multiple liver abscesses in a splenectomised patient

Talya Finn; Ami Schattner; Ina Dubin; Regev Cohen

An unusual case of infective endocarditis and concurrent multiple liver abscesses both caused by Streptococcus anginosus in a splenectomised patient is reported. The microorganism is a very rare cause of endocarditis and its presentation with multiple liver abscesses is highly unusual. It was initially misdiagnosed as Streptococcus sanguinis and issues relating to the different clinical presentations of S. anginosus including the rare cases of endocarditis, the role of the patient’s splenectomy and problems that may contribute to its potential laboratory misidentifications are discussed.


American Journal of Tropical Medicine and Hygiene | 2018

Case Report: Typhoid Fever and Spotted Fever Group Rickettsiosis Presenting Concomitantly in an Indian Immigrant

Regev Cohen; Frida Babushkin; Maurice Shapiro; Martina Uda; Yafit Atiya-Nasagi; Talya Finn

We present a rare case of an Indian immigrant suffering from concomitant infection of Salmonella typhi and spotted fever group Rickettsia. We discuss the scarce reports of dual infections from the developing world and the related diagnostic challenges.


Diagnostic Microbiology and Infectious Disease | 2017

Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study

Inbal Greenhouse; Frida Babushkin; Talya Finn; Zvi Shimoni; Moran Aliman; Ronen Ben-Ami; Regev Cohen

BACKGROUND To evaluate the short- and long-term outcomes of different antimicrobial treatment options for upper urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. METHODS We retrospectively analyzed patients with a first episode of febrile UTI and positive urine culture with ESBL-producing E. coli or K. pneumoniae during 2012-2015. We compared outcomes among patients who received: (1) definitive treatment with a carbapenem (CP), (2) a microbiologically appropriate intravenous non-carbapenem agent (NCA), (3) a non-appropriate antimicrobial (NAA), and (4) an intravenous NAA followed by an oral NCA (NAA-PO). RESULTS The majority of patients received empirical therapy with NAA (165/178, 93%), and definitive treatment with NCA (n=43), NAA (n=50), and NAA-PO (n=59). The NCA group had significantly higher SIRS score than the NAA-PO group (2.18 versus 1.76, P=0.018), but no differences were found between the NCA and NAA groups (2.18 and 1.92, P=0.15). Clinical cure at discharge from the index hospitalization was high (97-100%) in all 3 groups. The NCA group had longer length of stay as compared with the NAA-PO and NAA groups (8.7days versus 5.39 and 5.24days, P<0.0001) and a lower rate of early (48-72h) improvement (79% versus 96-100%, P=0.0002). Among re-admitted patients, re-admission with ESBL-related bloodstream infection was significantly higher in the NAA group as compared to the NAA-PO and NCA groups (33% versus 4% and 0%, respectively, P=0.02). Death rate within 60days was also higher in the NAA and NCA groups as compared with the NAA-PO group (P=0.048). CONCLUSIONS Inappropriate antimicrobial therapy for febrile non-bacteremic UTI with ESBL-producing enterobacteriaceae is associated with favorable short-term outcomes, but also with a long-term risk of relapsed bacteremic UTI. Definitive treatment with appropriate carbapenem-sparing antimicrobial agents effectively prevents late relapses.


American Journal of Tropical Medicine and Hygiene | 2014

An Ethiopian Woman with an Incidental Finding During a Cesarean Section

Regev Cohen; Igor Igov

This patient shows a rare phenomenon of schistosomal ova deposition on the serosal side of the small bowel without any pathology seen on the mucosal side of the small and large bowels. The patient was diagnosed accidentally during an elective cesarean section, when small nodules were seen on the small bowel surface.


American Journal of Infection Control | 2017

Water faucets as a source of Pseudomonas aeruginosa infection and colonization in neonatal and adult intensive care unit patients

Regev Cohen; Frida Babushkin; Zvi Shimoni; Shoshana Cohen; Eti Litig; Maurice Shapiro; Amos Adler; Svetlana Paikin


Travel Medicine and Infectious Disease | 2018

Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified cases

Matanelle Salama; Ziva Amitai; Yaniv Lustig; Zohar Mor; Miriam Weiberger; Michal Chowers; Shlomo Maayan; Oren Zimhony; Ronen Ben-Ami; Bibiana Chazan; Nelly Zaltzman-Bershadsky; Regev Cohen; Evgenia Tsyba; Rivka Sheffer; Emilia Anis; Yael Glazer; Silvia Pessah; Ella Mendelson; Eyal Leshem


Blood | 2017

Ibrutinib: A Risk Factor for Invasive Fungal Infections?

Rosa Ruchlemer; Ronen Ben Ami; Maskit Bar-Meir; Jennifer R. Brown; Marion Malphettes; Rogier Mous; Sanne H. Tonino; Carole Soussain; Noélie Barzic; Julia A. Messina; Preetesh Jain; Regev Cohen; Brian T. Hill; Stephen P. Mulligan; Marcel Nijland; Yair Herishanu; Ohad Benjamini; Tamar Tadmor; Koh Okamoto; Benjamin Arthurs; Jacob M. Rowe; Tamar Lachish

Collaboration


Dive into the Regev Cohen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ronen Ben-Ami

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge